ATE55134T1 - Salze von amino-beta-lactamsaeuren und verfahren zu ihrer herstellung. - Google Patents

Salze von amino-beta-lactamsaeuren und verfahren zu ihrer herstellung.

Info

Publication number
ATE55134T1
ATE55134T1 AT84401077T AT84401077T ATE55134T1 AT E55134 T1 ATE55134 T1 AT E55134T1 AT 84401077 T AT84401077 T AT 84401077T AT 84401077 T AT84401077 T AT 84401077T AT E55134 T1 ATE55134 T1 AT E55134T1
Authority
AT
Austria
Prior art keywords
atom
group
beta
methyl
hydrogen
Prior art date
Application number
AT84401077T
Other languages
English (en)
Inventor
Coll Alberto Palomo
Castellvi Juan Cabre
Coll Antonio Luis Palomo
Original Assignee
Gema Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gema Sa filed Critical Gema Sa
Application granted granted Critical
Publication of ATE55134T1 publication Critical patent/ATE55134T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT84401077T 1983-05-26 1984-05-24 Salze von amino-beta-lactamsaeuren und verfahren zu ihrer herstellung. ATE55134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES522728A ES8505362A1 (es) 1983-05-26 1983-05-26 "sales de acidos amino-beta-lactamicos, para su aplicacion a la obtencion de n-acil derivados de los mismos, y procedimiento para la obtencion de dichas sales"
EP84401077A EP0127541B1 (de) 1983-05-26 1984-05-24 Salze von Amino-beta-lactamsäuren und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE55134T1 true ATE55134T1 (de) 1990-08-15

Family

ID=8485785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84401077T ATE55134T1 (de) 1983-05-26 1984-05-24 Salze von amino-beta-lactamsaeuren und verfahren zu ihrer herstellung.

Country Status (8)

Country Link
US (1) US4659814A (de)
EP (1) EP0127541B1 (de)
JP (2) JPH07108896B2 (de)
AT (1) ATE55134T1 (de)
CA (1) CA1278568C (de)
DE (1) DE3482853D1 (de)
DK (1) DK174169B1 (de)
ES (1) ES8505362A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400717B (de) * 1993-07-30 1996-03-25 Biochemie Gmbh Neue guanidin- und amidinsalze von 7-amino-3- hydroxymethyl-3-cephem-4-carbonsäure
US5908929A (en) * 1996-12-05 1999-06-01 Vitara Chemicals Limited Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
GB0118764D0 (en) * 2001-08-01 2001-09-26 Biochemie Gmbh Organic compounds
JP2004253357A (ja) * 2002-05-09 2004-09-09 Wilson Greatbatch Technologies Inc 電気化学電源における常温溶融塩のためのカチオンとしてのグアニジン誘導体
US7214825B2 (en) 2003-10-17 2007-05-08 Honeywell International Inc. O-(3-chloropropenyl) hydroxylamine free base
CN102977122A (zh) * 2012-10-08 2013-03-20 江苏德峰药业有限公司 一种头孢替唑酸的制备方法
CN110317215A (zh) * 2019-07-26 2019-10-11 伊犁川宁生物技术有限公司 一种降低d-7-aca中do-7-aca杂质含量的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2865913A (en) * 1957-04-29 1958-12-23 Monsanto Canada Ltd Arylsulfonyl derivatives of bicyclic guanidines
EP0048953B1 (de) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-Lactam-Antibiotika
DK165118C (da) * 1980-11-22 1993-03-01 Gema Sa Fremgangsmaade til fremstilling af oploesninger af 7-aminocephalosporansyrer

Also Published As

Publication number Publication date
DK174169B1 (da) 2002-08-12
ES522728A0 (es) 1985-06-01
DE3482853D1 (de) 1990-09-06
JP2708724B2 (ja) 1998-02-04
JPH09110870A (ja) 1997-04-28
EP0127541B1 (de) 1990-08-01
US4659814A (en) 1987-04-21
EP0127541A2 (de) 1984-12-05
ES8505362A1 (es) 1985-06-01
DK255784A (da) 1984-11-27
JPS6034945A (ja) 1985-02-22
EP0127541A3 (en) 1985-11-06
DK255784D0 (da) 1984-05-24
CA1278568C (en) 1991-01-02
JPH07108896B2 (ja) 1995-11-22

Similar Documents

Publication Publication Date Title
PT97888A (pt) Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
KR870007163A (ko) 질소함유 융합 헤테로 사이클릭 화합물의 제조방법
ATE19513T1 (de) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE55134T1 (de) Salze von amino-beta-lactamsaeuren und verfahren zu ihrer herstellung.
CH614954A5 (en) Process for the preparation of substituted alpha-aminooxycarboxylic acid hydrazide derivatives and their acid addition salts
DE58900439D1 (de) N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung.
DE58903385D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
GB2017087A (en) Process for the preparation of xanthone derivatives
KR840006226A (ko) 티아트리아진 유도체의 제조방법
DE3685942D1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
KR100214400B1 (en) Preparation of substantially dust free tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione granules
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ES8606368A1 (es) Un procedimiento para producir un derivado de bencil-fosfi- nato etilico
ATE98248T1 (de) Verfahren zur herstellung von cephalosporinderivaten.
KR900003178A (ko) 세펨 화합물의 제조방법
ES450875A1 (es) Un procedimiento para la produccion de nuevos derivados de benzotiadiazol.
JPS56135488A (en) Novel preparative method of cephalosporanic acid derivative
DE59001784D1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ES8102115A1 (es) Procedimiento de preparacion de derivados de la xantona
SE7900889L (sv) Sett att framstella xantonderivat
TH4135EX (th) อนุพันธ์ต่าง ๆ ของพิริโดนคาร์บอกซิลิคแอซิค
MY101827A (en) 2-[n-substitutedguanidino]-4-heteroarylthiazole antiulcer agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time